FTF. Ya. Tukhasheva

F. Ya. Tukhasheva

*This is an algorithmically generated author record based on publicly available information.

F. Ya. Tukhasheva has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of the effects of trimeperidine and tafalgin as adjuncts to paracetamol-based analgesia in patients in the early postoperative period after coronary artery bypass grafting

    by L. S. Sorokina, O. N. Vasileva, N. M. Nemchinova, F. Ya. Tukhasheva, A. A. Eremenko, Л. С. Сорокина, О. Н. Васильева, Н. М. Немчинов, Ф. Я. Тухашева, А. А. Еременко

    Introduction . Moderate-to-severe postoperative pain may persist after coronary artery bypass grafting (CABG) despite baseline multimodal analgesia. The choice of an additional analgesic should take into account not only analgesic efficacy but also its safety profile. The objective was to compare the early effects of tafalgin and trimeperidine administered as adjuncts to baseline intravenous paracetamol analgesia in the early postoperative period after CABG. Materials and Methods . Sixty patients undergoing CABG were randomized using the sealed-envelope method into two groups (30 patients each). All patients received intravenous paracetamol (1 g four times daily), with the first dose administered 30 minutes before tracheal extubation. After extubation, patients experiencing their first pain episode with a visual analogue scale (VAS) score > 40 mm received a single dose of either intramuscular trimeperidine 20 mg or subcutaneous tafalgin 7 mg. Pain intensity (VAS), sedation level assessed using the Richmond Agitation–Sedation Scale (RASS), hemodynamic parameters, peripheral oxygen saturation (SpO₂), adverse events, and the need for rescue analgesia were evaluated before study drug administration and at 15, 30, 45, 60, and 120 minutes thereafter. Patients with persistent pain (VAS > 40 mm) at 60 minutes received intravenous nefopam 20 mg as rescue analgesia. Results . Baseline pain intensity did not differ between the groups: 58 [50–60] mm in the trimeperidine group and 60 [50–65] mm in the tafalgin group ( p = 0.49). At 15 minutes, pain intensity was lower in the trimeperidine group (38 [35–40] vs 45 [42–50] mm; p = 0.0006). No significant between-group differences in pain intensity were observed at 30, 45, 60, or 120 minutes. Heart rate was higher in the tafalgin group at 15 and 30 minutes ( p < 0.0001), whereas this difference was no longer significant by 45 minutes. Mild sedation (RASS −1) occurred more frequently in the trimeperidine group (57% vs 13%; p = 0.009). Nausea and vomiting were also more frequent after trimeperidine, although the differences did not reach statistical significance. The requirement for rescue analgesia with nefopam was comparable between the groups (17% vs 23%). Conclusion . A single 7 mg dose of tafalgin provided effective postoperative pain relief. Although trimeperidine produced faster pain relief during the first 15 minutes after administration, no significant differences in analgesic efficacy were observed thereafter. Tafalgin was associated with less sedation and a trend toward a lower incidence of postoperative nausea and vomiting, without increasing the need for rescue analgesia.

  • Open Access

    Indirect calorimetry as a non-invasive method of cardiorespiratory monitoring in the intraoperative period in cardiac surgical patients

    by L. S. Sorokina, S. S. Yudina, D. V. Fomina, M. A. Semenkov, F. Ya. Tukhasheva, A. V. Markova, S. V. Fedulova, A. A. Eremenko

    Introduction. Perioperative disturbances of energy metabolism in cardiac surgery patients significantly affect postoperative course and outcomes. Under conditions of surgical stress and cardiopulmonary bypass (CPB), conventional approaches to metabolic assessment have limited diagnostic value. The objective was to evaluate perioperative changes in cardiorespiratory function and energy metabolism in cardiac surgery patients with uncomplicated operations performed under general anesthesia using CPB. Materials and methods . Thirty patients were included in the study. Metabolic and hemodynamic parameters were assessed at four stages: after anesthesia induction, during sternotomy, before CPB initiation, and in the early post-perfusion period. Indirect calorimetry (IC) was used to measure oxygen consumption (VO2), carbon dioxide production (VCO 2 ), resting energy expenditure (REE), and respiratory quotient (RQ). Central hemodynamics were evaluated using transesophageal echocardiography. Blood gas parameters, lactate, and glucose levels were also analyzed. Results . The lowest VO 2 index values were recorded after anesthesia induction (106.55 ± 30.69 ml∙min –1 ⋅m –2 ), reflecting a state of pharmacologically induced metabolic suppression. From the sternotomy stage onward, a persistently increased level of energy expenditure was observed until the end of surgery. In the early post-perfusion period, VO 2 I index increased to 166.59 ± 44.69 ml ⋅ min –1 ⋅ m –2 , exceeding values calculated by the reverse Fick method by 76%. Predictive equations (Harris–Benedict) underestimated actual energy requirements by an average of 29%. Reduced RQ values (0.54–0.59) indicated predominant lipid substrate utilization. After CPB discontinuation, blood lactate levels increased 2.5-fold and blood glucose levels by 36%. A significant correlation between VO 2 and cardiac output was observed (r = 0.63; p = 0.001). Conclusion . Perioperative changes in energy metabolism are stage-dependent and predominantly adaptive in nature. Indirect calorimetry enables objective assessment of metabolic and perfusion status at different stages of cardiac surgery.

  • Open Access

    Analysis of the causes of lethal outcome in patients infected with human immunodeficiency virus

    by F. Ya. Tukhasheva, A. V. Markova, V. G. Zhelobov, O. G. Goryacheva, E. G. Malelin, K. D. Mekhonoshin, Тухашева Ф. Я.

    Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world. Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality. Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.